MLchartDataset catalogue

autologous anti-CD19 DASH CAR T cells

Term · Oncology and biomedicine · MLC-T-ONC-011374

A preparation of autologous T lymphocytes that have been genetically modified and transduced with a gamma-retrovirus vector expressing a second-generation chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 DASH CAR-T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies.

Table 1. Record
IdentifierMLC-T-ONC-011374
FieldOncology and biomedicine
SynonymsCD19 DASH CAR-T cells; CD19 targeted DASH CAR-T cells; autologous anti-CD19 CAR T cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011374",
  "term": "autologous anti-CD19 DASH CAR T cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that have been genetically modified and transduced with a gamma-retrovirus vector expressing a second-generation chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 DASH CAR-T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies.",
  "synonyms": [
    "CD19 DASH CAR-T cells",
    "CD19 targeted DASH CAR-T cells",
    "autologous anti-CD19 CAR T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-cd19-dash-car-t-cells/"
}

Record 2,706 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.